由于对其狼疮治疗的兴趣，ImmuPharma 的股价周一飙升了 39.7%，但两天后下跌了 15.6%。 ImmuPharma's stock soared 39.7% on Monday amid interest in its Lupus treatment but fell 15.6% two days later.

ImmuPharma是一家开发自发免疫疾病治疗办法的公司,星期一库存猛增39.7%,接近5.50GBX(0.07美元),交易量上升148%。 ImmuPharma, a company developing treatments for autoimmune diseases, saw its stock surge 39.7% on Monday, closing at GBX 5.50 ($0.07), with trading volume up 148%. 该公司的牵头方案P140(LupuzorTM)针对Lupus和其他自发免疫疾病。 The company's lead program, P140 (Lupuzor™), targets Lupus and other autoimmune diseases. ImmuPharma的市场最高限额为2 074万英镑。 ImmuPharma has a market cap of £20.74 million. 星期三,股票下跌15.6%,关闭时为4.98英镑(0.06美元)。 On Wednesday, the stock fell 15.6%, closing at GBX 4.98 ($0.06).